Carregant...
OptMAVEn-2.0: De novo Design of Variable Antibody Regions against Targeted Antigen Epitopes
Monoclonal antibodies are becoming increasingly important therapeutic agents for the treatment of cancers, infectious diseases, and autoimmune disorders. However, laboratory-based methods of developing therapeutic monoclonal antibodies (e.g., immunized mice, hybridomas, and phage display) are time-c...
Guardat en:
| Publicat a: | Antibodies (Basel) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6640672/ https://ncbi.nlm.nih.gov/pubmed/31544875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib7030023 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|